Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carace 10mg tablets
0205051L0BCACAC
|
Carace | Lisinopril | Cardiovascular System | No data available |
|
Carace 2.5mg tablets
0205051L0BCAAAA
|
Carace | Lisinopril | Cardiovascular System | No data available |
|
Carace 20 Plus tablets
0205051K0BCAAAA
|
Carace Plus | Lisinopril with diuretic | Cardiovascular System | No data available |
|
Carace 20mg tablets
0205051L0BCADAD
|
Carace | Lisinopril | Cardiovascular System | No data available |
|
Carace 5mg tablets
0205051L0BCABAB
|
Carace | Lisinopril | Cardiovascular System | No data available |
|
Carafate 1g tablets
0103030S0BDAAAA
|
Carafate | Sucralfate | Gastro-Intestinal System | No data available |
|
Caralpha 10mg/12.5mg tablets
0205051K0BDAAAB
|
Caralpha | Lisinopril with diuretic | Cardiovascular System | No data available |
|
Caralpha 20mg/12.5mg tablets
0205051K0BDABAA
|
Caralpha | Lisinopril with diuretic | Cardiovascular System | No data available |
|
Carbachol 3% eye drops
1106000J0AAAFAF
|
Carbachol (Eye) | Carbachol | Eye | No data available |
|
Carbaglu 200mg dispersible tablets
0908010ADBBAAAA
|
Carbaglu | Carglumic acid | Nutrition and Blood | No data available |
|
Carbalax suppositories
0106040N0BCAAAC
|
Carbalax | Phosphates (Rectal) | Gastro-Intestinal System | No data available |
|
Carbamazepine 10mg/5ml oral liquid
0408010C0AABGBG
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 200mg chewable tablets sugar free
0408010C0AAAKAK
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 35mg/5ml oral liquid
0408010C0AABEBE
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 40mg/5ml oral suspension
0408010C0AABHBH
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 50mg/5ml oral solution
0408010C0AABIBI
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbaryl 0.5% alcoholic lotion
1310040F0AAAAAA
|
Carbaryl | Carbaryl | Skin | No data available |
|
Carbaryl 1% aqueous liquid
1310040F0AAAFAF
|
Carbaryl | Carbaryl | Skin | No data available |
|
Carbellon tablets
010102100BBADA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Carbenoxolone 1% granules 2g sachets
1203010G0AAADAD
|
Carbenoxolone sodium (Mouthwash) | Carbenoxolone sodium | Ear, Nose and Oropharynx | No data available |
|
Carbetocin 100micrograms/1ml solution for injection ampoules
0701010W0AAAAAA
|
Carbetocin | Carbetocin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Carbetocin 100micrograms/1ml solution for injection vials
0701010W0AAABAB
|
Carbetocin | Carbetocin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Carbidopa 25mg tablets
0409010D0AAAAAA
|
Carbidopa | Carbidopa | Central Nervous System | No data available |
|
Carbimazole 1.25mg/5ml oral liquid
0602020D0AAAVAV
|
Carbimazole | Carbimazole | Endocrine System | No data available |
|
Carbimazole 1.5mg/5ml oral liquid
0602020D0AAAIAI
|
Carbimazole | Carbimazole | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.